Revision Year: 2019 Publisher: <u>Manufacturer:</u> Lead Chemical Co., Ltd., Hisagane Plant, 327 Hisagane Kamiichi-machi Nakaniikawa-gun, Toyama, Japan <u>Importer and marketing authorization holder:</u> ZUELLIG PHARMA LTD., Bangkok, ...
Loxoprofen sodium patch is contraindicated in the following patients.
Loxoprofen sodium patch should be administered with caution in the following patients: Patients with bronchial asthma (as the disease state may be exacerbated.)
Shock, anaphylaxis: Shock or anaphylaxis (decreased blood pressure, urticaria, laryngeal oedema, dyspnoea, etc.) may occur. Patients should be carefully monitored. If any abnormalities are observed, use of this drug should be discontinued immediately and appropriate measures should be taken."
Loxoprofen sodium patch should be used with careful monitoring of dermal condition of application area, in the elderly patients.
The safety of Loxoprofen sodium patch in low birth weight infants, newborn infants, infants and toddlers, children and adolescents has not been established (because there has been little experience of its use in pediatric patients).
Site of application:
Not applicable to both contraindications and precautions for coadministration.
Loxoprofen sodium patch should be administered to women who are or are possibly pregnant only when the anticipated therapeutic benefits are considered to outweigh any potential risk. [The safety of Loxoprofen sodium patch in these populations has not been established.]
It has been reported that constriction of the fetal ductus arteriosus is observed when woman in the late stage of pregnancy received other nonsteroidal anti-inflammatory analgesic drugs for external use.
There is no data available on effects on ability to drive and use machines.
0.5% to <3% | <0.5% | Incidence unknown | |
---|---|---|---|
Hypersensitivity | Pruritus, erythema, contact dermatitis, rash | Haemorrhage subcutaneous, skin irritation, pigment precipitation | Blister, swelling |
Gastrointestinal | Stomach discomfort, upper abdominal pain, diarrhea, loose stools | ||
Hepatic | Increased AST, increased ALT, increased γ−GTP | ||
Other | Edema |
No applicable data is available.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.